Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Lisi Zheng"'
Publikováno v:
International Journal of Medical Microbiology, Vol 316, Iss , Pp 151631- (2024)
Background: Clostridioides difficile infection (CDI) is an increasingly common disease in healthcare facilities and community settings. However, there are limited reports of community-onset CDI (CO-CDI) in China. Methods: We collected diarrheal stool
Externí odkaz:
https://doaj.org/article/e23362c2e1794f71a01537ed8fddfa60
Autor:
Miner Xie, Liwen Zhou, Ting Li, Yujie Lin, Ruhua Zhang, Xianchong Zheng, Cuiling Zeng, Lisi Zheng, Li Zhong, Xiaodan Huang, Yezi Zou, Tiebang Kang, Yuanzhong Wu
Publikováno v:
Advanced Science, Vol 11, Iss 22, Pp n/a-n/a (2024)
Abstract Bladder cancer (BC) is one of the most common tumors characterized by a high rate of relapse and a lack of targeted therapy. Here, YEATS domain‐containing protein 4 (YEATS4) is an essential gene for BC cell viability using CRISPR‐Cas9 li
Externí odkaz:
https://doaj.org/article/137cedf965a7493daa8dbbf0e0e9bef1
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
IntroductionEnterococcus faecium is a common pathogen responsible for urinary tract infections (UTIs) and often establishes extensive colonization within the intestinal tract. Our aim was to assess the genomic and transcriptomic differences between c
Externí odkaz:
https://doaj.org/article/7d8827008e03433197ff60e320504f33
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 30, Iss , Pp 252-258 (2022)
ABSTRACT: Objectives: Patients with inflammatory bowel disease (IBD) are susceptible to Clostridioides difficile infection (CDI), resulting in poor outcomes and recurrence; therefore, the molecular characterization of C. difficile in IBD patients in
Externí odkaz:
https://doaj.org/article/217848e37e8f4426b0ac8a30e1247b7d
Autor:
Zefu Liu, Xianchong Zheng, Jiawei Chen, Lisi Zheng, Zikun Ma, Lei Chen, Minhua Deng, Huancheng Tang, Liwen Zhou, Tiebang Kang, Yuanzhong Wu, Zhuowei Liu
Publikováno v:
Cell Reports, Vol 42, Iss 8, Pp 112963- (2023)
Summary: Dysregulation of transcription is a hallmark of cancer, including bladder cancer (BLCA). CRISPR-Cas9 screening using a lentivirus library with single guide RNAs (sgRNAs) targeting human transcription factors and chromatin modifiers is used t
Externí odkaz:
https://doaj.org/article/2eca148016f644c89ef0299cf07daf23
Autor:
Zhengjie Wu, Qiaomai Xu, Silan Gu, Yunbo Chen, Longxian Lv, Beiwen Zheng, Qiangqiang Wang, Kaicen Wang, Shuting Wang, Jiafeng Xia, Liya Yang, Xiaoyuan Bian, Xianwan Jiang, Lisi Zheng, Lanjuan Li
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Clostridioides difficile is a common cause of nosocomial infection. Antibiotic-induced dysbiosis in the intestinal microbiota is a core cause of C. difficile infection (CDI). Akkermansia muciniphila plays an active role in maintaining gastrointestina
Externí odkaz:
https://doaj.org/article/aebdd19194fd4d6d8fd08a2f3e527971
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
Patients with hepatic cirrhosis are more susceptible to Clostridioides difficile infection (CDI) and colonization with Clostridioides difficile (C. difficile). Asymptomatic C. difficile colonization is thought to predispose to subsequent CDI. However
Externí odkaz:
https://doaj.org/article/05495c72432c41f986cec11d78701739
Publikováno v:
Cancer Biology & Medicine, Vol 17, Iss 3, Pp 782-794 (2020)
Objective: Osteosarcoma is the most common primary malignant bone tumor. However, the survival of patients with osteosarcoma has remained unchanged during the past 30 years, owing to a lack of efficient therapeutic targets. Methods: We constructed a
Externí odkaz:
https://doaj.org/article/0b1b4c22ec874c668b87891023d2b8bf
Publikováno v:
Langmuir; 7/30/2024, Vol. 40 Issue 30, p15365-15388, 24p
Autor:
Yuanzhong Wu, Liwen Zhou, Yezi Zou, Yijun Zhang, Meifang Zhang, Liping Xu, Lisi Zheng, Wenting He, Kuai Yu, Ting Li, Xia Zhang, Zhenxuan Chen, Ruhua Zhang, Penghui Zhou, Nu Zhang, Limin Zheng, Tiebang Kang
Publikováno v:
Nature Cancer. 4:382-400
Immunotherapies targeting the PD-1/PD-L1 axis have become first-line treatments in multiple cancers. However, only a limited subset of individuals achieves durable benefits because of the elusive mechanisms regulating PD-1/PD-L1. Here, we report that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4485e7af403ade03f982f8d6dab78ed6
https://doi.org/10.1038/s43018-023-00522-1
https://doi.org/10.1038/s43018-023-00522-1